Selank vs Semax
The two leading Russian nootropic peptides compared head-to-head — anxiety relief vs cognitive enhancement, and when to use each.
Tuftsin analog
GABAergic anxiolytic · 751.86 Da · Thr-Lys-Pro-Arg-Pro-Gly-Pro
ACTH(4-7) analog
BDNF nootropic · 813.94 Da · Met-Glu-His-Phe-Pro-Gly-Pro
Selank and Semax are both synthetic heptapeptides developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. Despite their structural similarity and shared origin, they act on fundamentally different neurological pathways and serve distinct research purposes. Selank is the anxiolytic — it calms, stabilizes, and reduces stress reactivity. Semax is the nootropic — it sharpens focus, enhances memory consolidation, and provides neuroprotection. Understanding this distinction is the key to choosing the right compound, or deciding whether to use both.
Research Verdict
Complementary, not competing
Selank is the clear choice for anxiety, stress, and mood stabilization. Semax is the clear choice for cognitive enhancement, focus, and neuroprotection. For researchers targeting both anxiety reduction and cognitive performance, the combination ("Russian nootropic stack") is well-documented and the mechanisms are largely additive rather than redundant.
Pathway Comparison Diagram
Selank potentiates GABA-A receptors for anxiolytic effects without sedation; Semax upregulates BDNF/NGF for cognitive enhancement — complementary mechanisms that are commonly stacked.
What the cited studies used
One row per compound: the amount and schedule administered in a specific indexed study, who received it, and the paper. These are reports of what was done in that study, not recommendations, and several are animal or single-dose studies. Where no indexed human regimen exists we say so rather than print a number. Community "stacks" and cycle schedules are not reproduced on this site.
Research use only. Compound Review scores vendors on documentation — laboratory certificates, lot records, pricing and company identity. Nothing on this page is guidance on human or veterinary use, dosing or health outcomes.
| Compound | Regimen in the study | Population | Source |
|---|---|---|---|
| Selank | Administered for 14 days; amount not stated in the abstract Russian-language clinical study reporting cytokine markers; we cite the duration and population only. | Patients with generalised anxiety disorder and neurasthenia | PMID 18577961 Uchakina et al., Zh Nevrol Psikhiatr 2008 |
| Semax | No human dose-ranging trial in our reference set Semax is a registered intranasal preparation in Russia; the trials behind that registration are not PubMed-indexed in a form we have verified, so we print no amount. | — | none |
Selank vs Semax: Side-by-Side
| Category | Selank | Semax |
|---|---|---|
| Primary Use | Anxiety reduction, stress relief, mood stabilization | Cognitive enhancement, focus, neuroprotection |
| Origin | Synthetic tuftsin analog (Thr-Lys-Pro-Arg + Pro-Gly-Pro) | ACTH(4-7) fragment + Pro-Gly-Pro extension |
| Primary Mechanism | GABA-A modulation, serotonin turnover increase, cortisol reduction | BDNF upregulation, dopamine/serotonin enhancement, ACTH receptor binding |
| Anxiety Relief | Excellent — primary indication | Minimal — may worsen anxiety at high doses |
| Cognitive Enhancement | Mild — secondary effect via stress reduction | Excellent — primary indication |
| Neuroprotection | Moderate — via anti-inflammatory pathways | Strong — used clinically for stroke recovery in Russia |
| Immune Modulation | Yes — tuftsin-derived immunomodulatory activity | Mild — via ACTH pathway |
| Stimulant Effect | None — calming, non-sedating | Mild stimulant — increased alertness, energy |
| Typical Dose | See "What the cited studies used" | See "What the cited studies used" |
| Administration | Intranasal (preferred) or SubQ injection | Intranasal (preferred) or SubQ injection |
| Onset | 15–30 minutes (intranasal) | 15–30 minutes (intranasal) |
| Duration | 4–6 hours per dose | 4–8 hours per dose |
| Dependence Risk | None reported | None reported |
| Stackable Together? | Yes — complementary mechanisms | Yes — complementary mechanisms |
| Human Clinical Data | Russian trials for GAD, depression, PTSD | Russian trials for stroke, ADHD, cognitive impairment |
Mechanism of Action
Selank
Anxiolytic · Immunomodulator
Selank is a synthetic analog of tuftsin (Thr-Lys-Pro-Arg), an endogenous tetrapeptide derived from IgG that plays a role in immune regulation. The addition of the Pro-Gly-Pro tripeptide stabilizes the molecule and extends its half-life in vivo.
Its primary anxiolytic mechanism involves positive allosteric modulation of GABA-A receptors — similar in principle to benzodiazepines but without the sedation, tolerance, or dependence. Selank also increases serotonin turnover, reduces cortisol secretion under stress, and modulates the expression of BDNF, IL-6, and enkephalin-related genes.
Semax
Nootropic · Neuroprotective
Semax is a synthetic analog of the ACTH(4-7) fragment (Met-Glu-His-Phe) with a Pro-Gly-Pro C-terminal extension. Unlike full ACTH, it does not stimulate cortisol production — it retains the cognitive and neuroprotective effects of the ACTH fragment without the adrenal axis activation.
Its primary nootropic mechanism is upregulation of BDNF (brain-derived neurotrophic factor) and its receptor TrkB in the hippocampus, which enhances synaptic plasticity, memory consolidation, and neuronal survival. Semax also increases dopamine, serotonin, and noradrenaline signaling in the prefrontal cortex.
Which Should You Research?
Primary goal is anxiety reduction or stress management
→ Selank
GABAergic modulation without sedation or dependence risk. The most studied peptide for generalized anxiety in the Russian literature.
Primary goal is cognitive enhancement, focus, or memory
→ Semax
BDNF upregulation and dopaminergic enhancement are the most direct mechanisms for cognitive performance. Semax has the stronger evidence base for nootropic effects.
Neuroprotection after injury, stroke, or cognitive decline
→ Semax
Semax is used clinically in Russia for ischemic stroke recovery. Its BDNF-mediated neuroprotection is the most clinically validated effect of either peptide.
Anxiety-driven cognitive impairment (can't focus because of stress)
→ Selank first, or stack both
Anxiety-driven cognitive impairment responds better to anxiolytic treatment than direct nootropics. Selank removes the anxiety floor; Semax then enhances the cognitive ceiling.
Immune support alongside cognitive or mood optimization
→ Selank
Selank's tuftsin-derived immunomodulatory activity is a secondary benefit not shared by Semax. Relevant for researchers targeting both CNS and immune function.
Broad cognitive and mood optimization (no single dominant goal)
→ Stack both
The Selank + Semax combination is well-documented. Selank in the morning for baseline anxiety management; Semax for focused work sessions. Mechanisms are additive.
Research Protocols
Selank
Intranasal (amount: see cited studies)
1–2x daily, morning and/or afternoon
Cycle Length
2–4 weeks on
1–2 weeks off
Target
Generalized anxiety, stress reactivity, social anxiety, PTSD
Note: Selank is non-sedating and does not impair cognition. Can be used during work hours without performance impact.
Semax
Intranasal (amount: see cited studies)
1–2x daily, morning and early afternoon
Cycle Length
2–4 weeks on
1–2 weeks off
Target
Focus, memory consolidation, executive function, neuroprotection
Note: Avoid late-day dosing — Semax's mild stimulant effect can interfere with sleep. Start at the lower end of the dose range to assess individual response.
Selank
Intranasal (amount: see cited studies)
Morning (before work)
Semax
Intranasal (amount: see cited studies)
30 minutes after Selank
Target
Calm, focused cognition — anxiety floor + cognitive ceiling
Note: Selank first to establish the anxiolytic baseline, then Semax to layer cognitive enhancement on top. This sequence is commonly reported in the research community as producing the most balanced effect profile.
Research Evidence Summary
| Indication | Selank Evidence | Semax Evidence |
|---|---|---|
| Anxiety / GAD | Strong — multiple Russian RCTs, comparable to benzodiazepines without sedation | Weak — may worsen anxiety at high doses |
| Cognitive Enhancement | Moderate — secondary benefit via stress reduction | Strong — BDNF upregulation, multiple human studies |
| Memory Consolidation | Mild — indirect via cortisol reduction | Strong — hippocampal BDNF/TrkB activation |
| Neuroprotection | Moderate — anti-inflammatory, BDNF modulation | Strong — used clinically for stroke recovery in Russia |
| Depression | Moderate — serotonin and enkephalin modulation | Moderate — dopaminergic enhancement |
| ADHD / Focus | Mild — calming effect may help attention | Strong — dopamine/noradrenaline enhancement |
| Immune Function | Strong — tuftsin-derived immunomodulatory activity | Mild — ACTH pathway immune effects |
| Sleep Quality | Moderate — reduced anxiety improves sleep onset | Weak — stimulant effect may impair sleep if dosed late |
Frequently Asked Questions
What is the main difference between Selank and Semax?
Selank is primarily an anxiolytic and anti-stress peptide that calms the nervous system through GABAergic modulation and serotonin regulation. Semax is primarily a nootropic and neuroprotective peptide that enhances focus, memory, and cognitive performance through BDNF upregulation and dopaminergic signaling. Selank reduces anxiety; Semax sharpens cognition.
Which is better for anxiety — Selank or Semax?
Selank is the clear choice for anxiety. It modulates GABA-A receptors, increases serotonin turnover, and reduces cortisol without sedation or dependence. Semax can have mild anxiogenic effects in some users due to its dopaminergic and noradrenergic stimulation, making it less suitable as a primary anxiety treatment.
Which is better for focus and cognitive performance?
Semax is significantly more studied for cognitive enhancement. It upregulates BDNF in the hippocampus, enhances dopamine and serotonin signaling, and has demonstrated improvements in attention, memory consolidation, and executive function in both animal and human studies. Selank has mild nootropic effects but is not primarily a cognitive enhancer.
Can Selank and Semax be stacked together?
Yes — they are commonly stacked because their mechanisms are largely complementary. Selank provides the anxiolytic and mood-stabilizing floor while Semax provides the cognitive and focus ceiling. The combination is sometimes called the 'Russian nootropic stack' and is used in research protocols targeting both anxiety reduction and cognitive enhancement simultaneously.
How are Selank and Semax administered?
Both peptides are most commonly administered intranasally (nasal spray) because they cross the blood-brain barrier more efficiently via the olfactory route. Selank is also available as a subcutaneous injection. Semax is available as both intranasal and subcutaneous, with the intranasal route preferred for cognitive effects due to direct CNS delivery.
Which peptide has more clinical research?
Both were developed at the Institute of Molecular Genetics of the Russian Academy of Sciences and have been studied in Russia for decades. Semax has more published human clinical data, particularly for stroke recovery, ADHD, and cognitive impairment. Selank has strong preclinical data and several Russian clinical trials for generalized anxiety disorder and depression.
Are Selank and Semax safe?
Both have favorable safety profiles in research settings. Neither causes dependence, hormonal suppression, or significant organ toxicity at research doses. Selank is notably non-sedating compared to benzodiazepines. Semax can cause mild stimulant-like effects (increased heart rate, restlessness) at higher doses. Both are for research purposes only and not approved for human use in the US.
Related Comparisons
Related Guides
Ready to Start Your Research?
Purgo Labs provides pharmaceutical-grade Selank and Semax with third-party COAs. Use code HEALTH for 20% off your first order.
Shop Selank & Semax at Purgo Labs